何 中良

Medicine & Life Sciences

1. ErbB Receptors 100%
2. Neoplasms 93%
3. Mutation 93%
4. Non-Small Cell Lung Carcinoma 72%
5. Peripherins 68%
6. Urinary Bladder 59%
7. Carcinoma 58%
8. Intermediate Filament Proteins 57%
9. Liquid Biopsy 55%
10. Cytogenetics 49%
11. Loss of Heterozygosity 48%
12. Lung Neoplasms 47%
13. Transitional Cell Carcinoma 44%
14. rice bran saccharide 42%
15. Urinary Bladder Neoplasms 42%
16. Survival 40%
17. Hepatocellular Carcinoma 40%
18. Vimentin 36%
19. Genes 36%
20. Green Fluorescent Proteins 33%
21. L-Selectin 33%
22. Colorectal Neoplasms 33%
23. Peptide Nucleic Acids 31%
24. Cultured Cells 30%
25. Squamous Cell Carcinoma 29%
26. T-Cell Lymphoma 28%
27. Carcinogenesis 28%
28. Saliva 27%
29. Tumor Biomarkers 26%
30. Endometrium 25%
31. B-Cell Lymphoma 25%
32. Computational Biology 25%
33. Biomarkers 25%
34. capmatinib 25%
35. Mitogen-Activated Protein Kinases 24%
36. Cell Line 24%
37. Ligands 24%
38. Eye Manifestations 24%
39. Exons 24%
40. Microsatellite Repeats 23%
41. polyadenosine 23%
42. Adenocarcinoma of Lung 22%
43. T-Cell Receptor Genes 22%